The STEP 1 trial, in particular, showed that participants experienced an average weight loss of 14.9% over 68 weeks
Help is Available While there isnt a strict prohibition against drinking alcohol while taking GLP-1 medications, moderation and caution are advised
Patients should discuss with their provider: prior GLP-1 experience and tolerability, kidney and heart function status, family history of thyroid or pancreatic disease, and personal genetic predispositions in peptide pathways
When researchers used computer statistical modeling to see what could happen after more than a year off the medications, it suggested that those patients could regain about 75% of the weight they had lost
Protein at every meal is especially important reduced appetite on GLP-1 therapy creates a real risk of muscle loss if protein intake drops too low
The goal is not simply becoming lighter